Search Results for ""
- ACP Online (7495)
- Annals of Internal Medicine (6736)
- IM Matters (4542)
- ACP Hospitalist (2332)
- Annals of Internal Medicine: Clinical Cases (500)
- ACP Store (254)
Displaying 781 - 790 of 7495 in ACP Online
MKSAP 19 - CME, MOC, and CPD Information for Physicians
Dates and additional details pertaining to CME and MOC submissions for MKSAP.
MKSAP 19 - Resources
Access MKSAP 19 resources such as tips for using MKSAP to prepare for your next exam, tracker, and more.
MKSAP 19 Board Prep Webinar
MKSAP 19 editors provided tips and information for using MKSAP 19 to prepare for the ABIM Certification Exam. This webinar was held on February 21, 2023.
Maintain Your ABIM Certification with ACP's MKSAP 19 | ACP
Find out how the MKSAP® 19 can help you get ready for both of ABIM’s MOC Assessment options. Identify gaps, create a study approach & continue learning today!
MKSAP 19
Looking to earn CME & MOC credits as an internal medicine physician or resident while learning? View pricing, release dates, and order MKSAP 19 today.
Important Sales Tax Information
The American College of Physicians (ACP) is required by law to collect sales tax on orders fulfilled to customers within states where ACP has nexus. Sales tax is a combined total of state, county, city, and district tax rates (where applicable). ACP remits all sales taxes collected to the appropriate taxing jurisdictions. If your order is subject to sales tax and it was not charged, you may be responsible for remitting use tax to the proper taxing jurisdiction. Information about use tax may be found on the website(s) of your respective taxing authorities.
View Critical Care Video Shorts
A new and innovative way to learn or review important critical care topics, this unique training series provides essential content needed for intensive care practice. Assessment of Oxygenation View videos Videos include:
Critical Care Video Shorts
A new and innovative way to prepare your interns for their initial critical care rotations, or provide a review of important critical care topics for more advanced residents and practicing physicians.This unique training series provides essential content needed for intensive care practice. Presented in 2- to 5-minute key segments in an engaging animated white board style, these high-quality, educational videos can be viewed any time, in any order and are mobile friendly.
The New ACP MKSAP: Information for Educators Webinar
Watch the presentation below and read questions and answers submitted during the webinar.
ACP MKSAP Staff & Contributors
MKSAP has been conceived and produced within the ACP Medical Education Division under the general leadership of Davoren Chick, MD, FACP, Chief Learning Officer and Senior Vice President; Margaret Wells, EdM, Vice President, Learning Assessment, Accreditation & Research; and Becky Krumm, Director, Assessment and Education Programs.
Displaying 781 - 790 of 6736 in Annals of Internal Medicine
These Annals of Internal Medicine results only contain recent articles.
- Visit annals.org to search all content back to 1927.
- View Annals of Internal Medicine CME by topic here.
Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak: A Retrospective Cohort Study: Annals of Internal Medicine: Vol 176, No 5
Background: The recent mpox outbreak has disproportionately affected people with HIV (PWH) and resulted in the first widespread use of the novel antiviral tecovirimat. Whether treatment outcomes differ between PWH and those without HIV is unknown. Objective: To compare the clinical presentation and treatment outcomes of PWH and HIV-negative persons with mpox virus (MPXV) infection treated with tecovirimat. Design: Retrospective cohort study of patients treated with tecovirimat for confirmed MPXV infection from June to August 2022. Setting: Two academic medical centers in New York City. Participants: The study included 196 persons treated with tecovirimat from 20 June to 29 August 2022. Of 154 testing positive for MPXV, 72 were PWH and 4 had a CD4 count lower than 0.20 × 109 cells/L. Measurements: Patient demographic characteristics, clinical presentation, treatment outcomes, and safety data for tecovirimat. Results: Indications for tecovirimat treatment were similar between the PWH and HIV-negative groups. Four participants had serious adverse events; none were attributed to tecovirimat. Three of these 4 participants had HIV infection, and 2 had CD4 counts less than 0.20 × 109 cells/L. Twenty-two percent of participants had nonsevere adverse effects. Groups had similar rates of hospitalization, indications for treatment, and co-occurring infections, but PWH had fewer days from symptom onset to treatment (7.5 vs. 10). There was no difference in treatment outcomes, including days to improvement or rate of persistent symptoms. Limitation: Patients with mpox who were not treated with tecovirimat were not followed routinely and therefore lacked comparable outcome data, limiting evaluation of efficacy. Conclusion: In our cohort of patients treated with tecovirimat for severe mpox, HIV status did not seem to affect treatment outcomes. Primary Funding Source: National Institutes of Health.
Temporal Trends in the Use of Computed Tomographic Pulmonary Angiography for Suspected Pulmonary Embolism in the Emergency Department: A Retrospective Analysis: Annals of Internal Medicine: Vol 176, No 6
Background: Recently, validated clinical decision rules have been developed that avoid unnecessary use of computed tomographic pulmonary angiography (CTPA) in patients with suspected pulmonary embolism (PE) in the emergency department (ED). Objective: To measure any resulting change in CTPA use for suspected PE. Design: Retrospective analysis. Setting: 26 European EDs in 6 countries. Patients: Patients with CTPA performed for suspected PE in the ED during the first 7 days of each odd month between January 2015 and December 2019. Measurements: The primary end points were the CTPAs done for suspected PE in the ED and the number of PEs diagnosed in the ED each year adjusted to an annual census of 100 000 ED visits. Temporal trends were estimated using generalized linear mixed regression models. Results: 8970 CTPAs were included (median age, 63 years; 56% female). Statistically significant temporal trends for more frequent use of CTPA (836 per 100 000 ED visits in 2015 vs. 1112 in 2019; P < 0.001), more diagnosed PEs (138 per 100 000 in 2015 vs. 164 in 2019; P = 0.028), a higher proportion of low-risk PEs (annual percent change [APC], 13.8% [95% CI, 2.6% to 30.1%]) with more ambulatory management (APC, 19.3% [CI, 4.1% to 45.1%]), and a lower proportion of intensive care unit admissions (APC, −8.9% [CI, −17.1% to −0.3%]) were observed. Limitation: Data were limited to 7 days every 2 months. Conclusion: Despite the recent validation of clinical decision rules to limit the use of CTPA, an increase in the CTPA rate along with more diagnosed PEs and especially low-risk PEs were instead observed. Primary Funding Source: None specific for this study.